You seem confused, AP464 showed potent inhibition of Bcr-Abl. It was only replaced by AP534 once AP534 was shown to also be effective against the T315I mutation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.